Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2009

Eurogentec Gains License from Applied Biosystems to Produce Oligonucleotide Probes

  • Eurogentec obtained a license from Applied Biosystems to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5´ Nuclease process. This process is one of the key technologies driving real-time PCR assays. 

    Eurogentec will be able to custom manufacture, market, and sell dual-labeled probes alone as well as in complete kits. These kits may contain dual-labeled probes, primers, and reagents packaged and sold with other components. The agreement grants limited pass-through use rights to Eurogentec’s research customers. The agreement also conveys rights to offer oligonucleotide design services for probes and primers for use in real-time PCR.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »